McGill University-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:McGill University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014130
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥26,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥53,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥80,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
McGill University (McGill) is a research based educational institute. The university offers undergraduate, graduate and post-graduate courses. It provides academic courses across various disciplines including agricultural and environmental sciences, arts, dentistry, education, engineering, law, management, medicine, music and science among others. The university carries research and licensing technologies in several domains which include agriculture, mechanical and materials, genomics and proteomics, nanotechnologies, climate research, biomedical, network communications, food technology, clean technology, therapeutic agents. McGill works in collaboration with hospitals, research institutions and health centers such as Jewish General Hospital, The Shriners Hospital, St. Mary’s Hospital Center and Douglas Mental Health University Institute. McGill is headquartered in Montreal, Quebec, Canada.

McGill University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
McGill University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
McGill University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
McGill University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
McGill University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
McGill University, Medical Devices Deals, 2011 to YTD 2017 10
McGill University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
McGill University, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Lead Discovery Center Enters into Research Agreement with McGill University 13
Proove Biosciences Enters into Partnership with McGill University 14
B Cell Design Enters into R&D Agreement with McGill University 15
IASO BioMed Enters into Research Agreement with Research Institute of the McGill University 16
Cyclenium Pharma Enters into Research Agreement with McGill University 17
Neomed Institute Partners with McGill University 18
MSBi Valorisation, McGill University and Research Institute of the McGill University Health Centre Form Partnership 19
Viteava Pharma Enters Into Research Agreement With Mcgill University 20
PharmaNet Canada Forms Joint Venture With The Research Institute Of McGill University Health Centre 21
GlaxoSmithKline Enters Into Co-Development Agreement With McGill University 22
Licensing Agreements 23
Corbin Therapeutics Enters into License Agreement with McGill University 23
IASO BioMed Enters into Licensing Agreement with McGill University 24
AUM LifeTech Enters into Licensing Agreement with McGill University 25
Kinex Pharma Enters into Licensing Agreement with Hong Kong Polytechnic University and McGill University 26
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 27
Domain Therapeutics Extends its Licensing Agreement with Universite de Montreal and McGill University 28
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 30
Raptor Pharma Enters Into Licensing Agreement With McGill University For IP Rights Related To Malaria 32
Asset Transactions 33
Kanyr Pharma Acquires Rights for Two Cancer Programs from McGill University 33
McGill University – Key Competitors 34
McGill University – Key Employees 35
McGill University – Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Joint Venture 36
Recent Developments 37
Strategy And Business Planning 37
Jan 09, 2017: Amorchem Spins Out Its USP15-deubiquitinylation (DUB) Drug Discovery Platform Into Corbin Therapeutics, With A First 1M $ Seed Investment 37
Government and Public Interest 38
Oct 23, 2017: Transformative donation of $16 million establishes new autism research centre at the Montreal Neurological Institute 38
Oct 13, 2017: New mechanism detected in Alzheimer’s disease 39
Oct 13, 2017: Neurotechnological innovation and organ-on-a-chip engineering centres receive more than $10 million in new funding 40
Sep 06, 2017: Scientists link 153 new genetic variants to osteoporosis in largest ever study 41
May 15, 2017: Diabetes drug may help symptoms of autism associated condition 42
Jan 09, 2017: Breakthrough in MS treatment 43
Oct 18, 2016: RI-MUHC researchers discover new path to stop the spread of cancer 44
Oct 03, 2016: KalGene gears up to manufacture and test promising Alzheimer’s treatment with NRC, McGill and CIMTEC 45
Sep 22, 2016: Kenneth Rainin Foundation Awards Over $3 Million to High-Risk, High Reward Inflammatory Bowel Disease Research Projects 46
Sep 15, 2016: €12.6 Million Awarded to 3 Projects in Global Effort to End Progressive Multiple Sclerosis 48
Sep 07, 2016: Medication against schizophrenia inhibits pancreatic cancer 50
Sep 06, 2016: McGill wins $84 million grant for neuroscience 51
Sep 01, 2016: Ferring Canada Donates $2 Million to McGill University 52
Aug 15, 2016: Legions of nanorobots target cancerous tumours with precision – Administering anti-cancer drugs redefined 53
Aug 01, 2016: Adverse Effects and Incretin-based Drugs for Diabetes 54
Apr 20, 2016: Brighter prospects for chronic pain 55
Feb 15, 2016: Vulnerability to depression linked to noradrenaline 56
Jan 20, 2016: Using light for targeted drug delivery could help fight tumors, local infections 57
Other Significant Developments 58
Oct 20, 2016: Easing the burden of terminal illness 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
McGill University, Pharmaceuticals & Healthcare, Key Facts 2
McGill University, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
McGill University, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
McGill University, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
McGill University, Deals By Therapy Area, 2011 to YTD 2017 9
McGill University, Medical Devices Deals, 2011 to YTD 2017 10
McGill University, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Lead Discovery Center Enters into Research Agreement with McGill University 13
Proove Biosciences Enters into Partnership with McGill University 14
B Cell Design Enters into R&D Agreement with McGill University 15
IASO BioMed Enters into Research Agreement with Research Institute of the McGill University 16
Cyclenium Pharma Enters into Research Agreement with McGill University 17
Neomed Institute Partners with McGill University 18
MSBi Valorisation, McGill University and Research Institute of the McGill University Health Centre Form Partnership 19
Viteava Pharma Enters Into Research Agreement With Mcgill University 20
PharmaNet Canada Forms Joint Venture With The Research Institute Of McGill University Health Centre 21
GlaxoSmithKline Enters Into Co-Development Agreement With McGill University 22
Corbin Therapeutics Enters into License Agreement with McGill University 23
IASO BioMed Enters into Licensing Agreement with McGill University 24
AUM LifeTech Enters into Licensing Agreement with McGill University 25
Kinex Pharma Enters into Licensing Agreement with Hong Kong Polytechnic University and McGill University 26
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 27
Domain Therapeutics Extends its Licensing Agreement with Universite de Montreal and McGill University 28
Viteava Pharma Enters Into Licensing Agreement For Intellectual Property Portfolio Of Analogs And Derivatives 30
Raptor Pharma Enters Into Licensing Agreement With McGill University For IP Rights Related To Malaria 32
Kanyr Pharma Acquires Rights for Two Cancer Programs from McGill University 33
McGill University, Key Competitors 34
McGill University, Key Employees 35
McGill University, Subsidiaries 36
McGill University, Joint Venture 36

★海外企業調査レポート[McGill University-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bank AlJazira:企業の戦略・SWOT・財務情報
    Bank AlJazira - Strategy, SWOT and Corporate Finance Report Summary Bank AlJazira - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Cayenne Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cayenne Medical Inc (Cayenne Medical), a subsidiary of Zimmer Biomet Holdings Inc, is a soft-tissue reconstruction service provider. The company provides knee and shoulder implant products. It offers products such as aperfix femoral, aperfix II tibial, mirror partial knee, cross fix meniscal …
  • Immuron Ltd (IMC)-製薬・医療分野:企業M&A・提携分析
    Summary Immuron Ltd (Immuron), formerly Anadis Limited is a biopharmaceutical company that conducts research and develops polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. Immuron’s products …
  • Autoliv Inc (ALV):企業の財務・戦略的SWOT分析
    Autoliv Inc (ALV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Taiwan Semiconductor Manufacturing Company Limited (2330):企業のM&A・提携動向(発電分野)
    Summary Taiwan Semiconductor Manufacturing Company Limited (TSMC) is a provider of semiconductor foundry services. The company manufactures customized logic semiconductors, mixed signal and radio frequency (RF) semiconductors, memory semiconductors, CMOS image sensor semiconductors and high voltage …
  • Veolia Environnement SA (VIE):企業のM&A・提携動向(エネルギー分野)
    Summary Veolia Environnement SA (Veolia) is an optimized resource management company. It designs, develops and provides water, waste and energy management solution solutions. The company specializes in providing water and wastewater services, environmental services and energy services for the develo …
  • StemCells, Inc. (STEM):企業の財務及び戦略的SWOT分析
    Summary StemCells, Inc. (StemCells), a subsidiary of Stem Cell Sciences UK Ltd is a pharmaceutical company that conducts research, develops and commercializes cell based therapeutics and related tools. It provides research on products for spinal cord injury, thoracic injury, cervical injury, retinal …
  • Fan Milk Limitedの企業概要及び財務/SWOT分析
    Fan Milk Limited Fundamental Company Report provides a complete overview of the company’s affairs. The report includes financial and SWOT information, industry analysis, opinions, estimates, Fan Milk Limited annual and quarterly forecasts made by stock market experts. The report also enables direct …
  • First Derivatives plc (FDP):企業の財務・戦略的SWOT分析
    First Derivatives plc (FDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Dechra Pharmaceuticals Plc (DPH):企業の財務及び戦略的SWOT分析
    Summary Dechra Pharmaceuticals Plc (Dechra) is a pharmaceutical company that develops and markets animal healthcare products. The company offers products such as Alvegesic vet, Canaural, Cardisure, Comfortan, Cyclospray, Eclypse, Equipalazone, Felimazole, Fuciderm, Lignol, Lubrel, Malaseb, Methoxaso …
  • EWA Government Systems, Inc.:企業の戦略・SWOT・財務分析
    SummaryEWA Government Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company …
  • CNH Industrial N.V. – Construction Equipment Segment:企業の戦略、SWOT、動向分析
    The report is a comprehensive, strategic resource on CNH Industrial N.V. providing key insights, analysis & information on the company. The initial sections provide a snapshot & overview on the business operations & market positioning of the company while the SWOT framework analyzes the core Strengt …
  • Nexans Maroc S.A. (NEX):企業概要、財務及び戦略的SWOT分析
    Summary Nexans Maroc S.A. (Nexans Maroc) is an electrical equipment manufacturing company. The company manufactures and markets electrical cables and other electrical products. It offers transmission and distribution of energy sector products. Nexans Maroc’s industrial cabling products include cable …
  • Wah Seong Corporation Berhad (WASEONG):企業概要、財務及び戦略的SWOT分析
    Summary Wah Seong Corporation Berhad (Wah Seong Corp) is an oil service company. The company provides renewable energy, industrial trading and services, oil and gas, and other services. It offers pipeline services, engineering services, E and P services, renewable energy, plantation, infrastructure …
  • Blue Frog Solutions, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Blue Frog Solutions, Inc. Merge …
  • NEC Corporation:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' NEC Corporation Mergers and Acq …
  • Flatiron Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Flatiron Health Inc (Flatiron Health) a subsidiary of F. Hoffmann-La Roche Ltd, is a healthcare technology company which develops a learning healthcare system in oncology. The company offers a web-based business and clinical intelligence data platform that integrates and structures disparate …
  • Spire, Inc.:戦略・SWOT・企業財務分析
    Spire, Inc. - Strategy, SWOT and Corporate Finance Report Summary Spire, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Delta Electricity:企業の発電所・SWOT分析2018
    Delta Electricity - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Poupart Limited:企業概要およびSWOT分析
    Summary Canadean's "Poupart Limited: Foodservice - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, ke …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆